Japan Vietnam Medical Instrument JSC
Vietnam Medical and Pharmaceutical Investment Joint Stock Company engages in the distribution of medical equipment and instruments in Vietnam. The company distributes medical equipment, including diagnostic imaging products, such as magnetic resonance imaging (MRI), computed tomography (CT), x-ray systems, computed and direct radiography, dry imagers, contrast injectors, and diagnostic ultrasound… Read more
Japan Vietnam Medical Instrument JSC (JVC) - Net Assets
Latest net assets as of December 2022: ₫441.28 Billion VND
Based on the latest financial reports, Japan Vietnam Medical Instrument JSC (JVC) has net assets worth ₫441.28 Billion VND as of December 2022.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₫587.02 Billion) and total liabilities (₫145.74 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₫441.28 Billion |
| % of Total Assets | 75.17% |
| Annual Growth Rate | -10.58% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 3.95 |
Japan Vietnam Medical Instrument JSC - Net Assets Trend (2020–2022)
This chart illustrates how Japan Vietnam Medical Instrument JSC's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Japan Vietnam Medical Instrument JSC (2020–2022)
The table below shows the annual net assets of Japan Vietnam Medical Instrument JSC from 2020 to 2022.
| Year | Net Assets | Change |
|---|---|---|
| 2022-03-31 | ₫424.98 Billion | -6.54% |
| 2021-03-31 | ₫454.69 Billion | -14.43% |
| 2020-03-31 | ₫531.38 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Japan Vietnam Medical Instrument JSC's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 10662914636300.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (March 2022)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | ₫1.55 Trillion | 364.10% |
| Total Equity | ₫424.75 Billion | 100.00% |
Japan Vietnam Medical Instrument JSC Competitors by Market Cap
The table below lists competitors of Japan Vietnam Medical Instrument JSC ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Penta Teknoloji Urunleri Dagitim Ticaret AS
IS:PENTA
|
$16.88 Million |
|
Hansol Homedec
KO:025750
|
$16.88 Million |
|
Kumpulan Kitacon Berhad
KLSE:5310
|
$16.89 Million |
|
Sino Green Land Corporation
PINK:SGLA
|
$16.89 Million |
|
Quaint Oak Bancorp Inc
OTCQB:QNTO
|
$16.86 Million |
|
PENGUIN INTL LTD.
F:O1U1
|
$16.86 Million |
|
Surge Copper Corp
OTCQB:SRGXF
|
$16.86 Million |
|
NETWORK-1 TECH.INC.DL-01
F:6LK
|
$16.85 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Japan Vietnam Medical Instrument JSC's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2021 to 2022, total equity changed from 454,692,353,573 to 424,749,026,636, a change of -29,943,326,937 (-6.6%).
- Net loss of 29,943,326,937 reduced equity.
Equity Change Factors (2021 to 2022)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₫-29.94 Billion | -7.05% |
| Total Change | ₫- | -6.59% |
Book Value vs Market Value Analysis
This analysis compares Japan Vietnam Medical Instrument JSC's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.19x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has increased from 0.95x to 1.19x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2020-03-31 | ₫4723.35 | ₫4490.00 | x |
| 2021-03-31 | ₫4041.70 | ₫4490.00 | x |
| 2022-03-31 | ₫3775.54 | ₫4490.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Japan Vietnam Medical Instrument JSC utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -7.05%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -7.65%
- • Asset Turnover: 0.65x
- • Equity Multiplier: 1.41x
- Recent ROE (-7.05%) is above the historical average (-7.80%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2020 | 0.53% | 0.54% | 0.81x | 1.20x | ₫-50.34 Billion |
| 2021 | -16.87% | -18.64% | 0.66x | 1.38x | ₫-122.16 Billion |
| 2022 | -7.05% | -7.65% | 0.65x | 1.41x | ₫-72.42 Billion |
Industry Comparison
This section compares Japan Vietnam Medical Instrument JSC's net assets metrics with peer companies in the Medical Devices industry.
No peer company data available for comparison.